FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE

VANCOUVER, BC, Dec. 18, 2023 /CNW/ - Filament Health Corp.  , a clinical‐stage natural psychedelic drug development company, today announced that the special meeting of its securityholders held...

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,Delaware ,United States ,British ,Canadian ,Benjamin Lightburn ,Jeremy Weech ,Davida Donohoe Jr ,Donohoe Advisory Associates ,Filament Health Corp ,Helena Partners Inc ,Twitter ,Nasdaq ,Counsel For The Listing Qualifications Department ,Instagram ,Bc Ltd ,Exchange Commission ,Jupiter Acquisition Corporation ,Linkedin ,Filament Health ,Business Corporations Act ,Special Meeting ,Arrangement Resolution ,Helena Global Investment Opportunities ,Proposed Business Combination ,Helena Financing ,Note Financing ,Chief Counsel ,Listing Qualifications Department ,Nasdaq Stock Market ,Donohoe Advisory ,Filament Chief Executive Officer ,Helena Managing Partner ,New Year ,Information About ,Health Corp ,Proposed Business ,Registration Statement ,Annual Report ,Canada Newswire ,Markets ,